Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, signaling a minor update to the page's release or documentation and not altering substantive information presented to users.
    Difference
    0.1%
    Check dated 2026-05-18T04:16:08.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page revision/version updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:24:09.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:41:32.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; there are no visible edits to the study details content.
    Difference
    0.1%
    Check dated 2026-03-21T16:52:39.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T13:19:07.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the conditions list. The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T17:32:06.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.